Novartis, Actavis Settle Patent Infringement Suit
Novartis Pharmaceuticals Corp. and Actavis LLC have agreed to settle claims that the generic drug maker's use of a drug ingredient infringed Novartis' patents, according to a court documents filed in...To view the full article, register now.
Already a subscriber? Click here to view full article